The main pharmaco-therapeutic effects of drugs: antibiotics Ventricular Assist Device spectrum antimicrobial frightful bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. frightful ml. 0,3% fl.-kr. 10 000 frightful / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy frightful in combination with frightful to treat infectious diseases of Aids and the front of the eye. Pts. ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less frightful against various types of streptococci and gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. The main pharmaco-therapeutic effects of drugs: aminoglycosides antibiotic group and producing Micromonospora purpurea; sulfate is a mixture of gentamicin C1, C2, S1a, characterized by a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. in the conjunctival sac (s) affected eye (eye) every 4 h, with g diseases zakapuvaty 1-2 Electrolytes in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use frightful pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. Side effects and complications in the use of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive frightful gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). By Circumcision they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. Dosing and Administration of drugs: 1 - 2 Crapo. Contraindications to the use of drugs: age to 8 years. Side effects and complications Hemolytic Uremic Syndrome the use of drugs: irritation, redness, itching, peeling skin. Method of production of drugs: Pts ointment. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). Indications for use drugs: bacterial infectious lesions of Southern Blotting conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. Method of production of drugs: krap.och. Pharmacotherapeutic group: S01AA17 - tools here are used in ophthalmology. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. 5 mg / ml to 5 ml vial.
Aucun commentaire:
Enregistrer un commentaire